The regular clinical follow-up of patients with chronic liver disease - including cirrhosis, viral hepatitis or primary sclerosing cholangitis - facilitates early detection of cholangiocarcinoma, aggressive liver cancer and high mortality if not detected in early stages.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The regular clinical follow-up of patients with chronic liver disease - including cirrhosis, viral hepatitis or primary sclerosing cholangitis - facilitates early detection of cholangiocarcinoma, aggressive liver cancer and high mortality if not detected in early stages.